vs

Side-by-side financial comparison of BlackSky Technology Inc. (BKSY) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.

BlackSky Technology Inc. is the larger business by last-quarter revenue ($35.2M vs $18.3M, roughly 1.9× ROCKWELL MEDICAL, INC.). BlackSky Technology Inc. runs the higher net margin — -2.5% vs -3.0%, a 0.6% gap on every dollar of revenue. On growth, BlackSky Technology Inc. posted the faster year-over-year revenue change (15.9% vs -25.6%). Over the past eight quarters, BlackSky Technology Inc.'s revenue compounded faster (20.5% CAGR vs -10.1%).

BlackSky Technology Inc. is a leading geospatial intelligence provider operating a constellation of high-revisit small Earth observation satellites. It delivers real-time satellite imagery, advanced data analytics, and dynamic monitoring solutions to government, defense, critical infrastructure, and commercial clients globally to support data-driven operational decision-making.

Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).

BKSY vs RMTI — Head-to-Head

Bigger by revenue
BKSY
BKSY
1.9× larger
BKSY
$35.2M
$18.3M
RMTI
Growing faster (revenue YoY)
BKSY
BKSY
+41.6% gap
BKSY
15.9%
-25.6%
RMTI
Higher net margin
BKSY
BKSY
0.6% more per $
BKSY
-2.5%
-3.0%
RMTI
Faster 2-yr revenue CAGR
BKSY
BKSY
Annualised
BKSY
20.5%
-10.1%
RMTI

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BKSY
BKSY
RMTI
RMTI
Revenue
$35.2M
$18.3M
Net Profit
$-868.0K
$-554.0K
Gross Margin
21.1%
Operating Margin
-11.8%
-2.2%
Net Margin
-2.5%
-3.0%
Revenue YoY
15.9%
-25.6%
Net Profit YoY
95.5%
26.7%
EPS (diluted)
$0.04
$-0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BKSY
BKSY
RMTI
RMTI
Q4 25
$35.2M
$18.3M
Q3 25
$19.6M
$15.9M
Q2 25
$22.2M
$16.1M
Q1 25
$29.5M
$18.9M
Q4 24
$30.4M
$24.7M
Q3 24
$22.5M
$28.3M
Q2 24
$24.9M
$25.8M
Q1 24
$24.2M
$22.7M
Net Profit
BKSY
BKSY
RMTI
RMTI
Q4 25
$-868.0K
$-554.0K
Q3 25
$-15.3M
$-1.8M
Q2 25
$-41.2M
$-1.5M
Q1 25
$-12.8M
$-1.5M
Q4 24
$-19.4M
$-756.0K
Q3 24
$-12.6M
$1.7M
Q2 24
$-9.4M
$343.0K
Q1 24
$-15.8M
$-1.7M
Gross Margin
BKSY
BKSY
RMTI
RMTI
Q4 25
21.1%
Q3 25
14.3%
Q2 25
15.6%
Q1 25
16.1%
Q4 24
14.7%
Q3 24
22.0%
Q2 24
17.6%
Q1 24
13.5%
Operating Margin
BKSY
BKSY
RMTI
RMTI
Q4 25
-11.8%
-2.2%
Q3 25
-85.8%
-9.9%
Q2 25
-62.8%
-8.4%
Q1 25
-40.5%
-7.2%
Q4 24
-20.0%
-2.1%
Q3 24
-58.7%
6.8%
Q2 24
-47.0%
2.0%
Q1 24
-54.7%
-5.8%
Net Margin
BKSY
BKSY
RMTI
RMTI
Q4 25
-2.5%
-3.0%
Q3 25
-78.2%
-11.0%
Q2 25
-185.8%
-9.3%
Q1 25
-43.4%
-8.0%
Q4 24
-63.9%
-3.1%
Q3 24
-55.8%
5.9%
Q2 24
-37.7%
1.3%
Q1 24
-65.2%
-7.6%
EPS (diluted)
BKSY
BKSY
RMTI
RMTI
Q4 25
$0.04
$-0.01
Q3 25
$-0.44
$-0.05
Q2 25
$-1.27
$-0.05
Q1 25
$-0.42
$-0.04
Q4 24
$-0.61
$-0.02
Q3 24
$-0.66
$0.04
Q2 24
$-0.52
$0.01
Q1 24
$-0.88
$-0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BKSY
BKSY
RMTI
RMTI
Cash + ST InvestmentsLiquidity on hand
$124.5M
$10.7M
Total DebtLower is stronger
$201.1M
Stockholders' EquityBook value
$94.9M
$37.0M
Total Assets
$386.2M
$57.1M
Debt / EquityLower = less leverage
2.12×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BKSY
BKSY
RMTI
RMTI
Q4 25
$124.5M
$10.7M
Q3 25
$146.5M
$13.6M
Q2 25
$93.8M
$12.5M
Q1 25
$75.8M
$11.4M
Q4 24
$52.5M
$15.7M
Q3 24
$63.2M
$12.3M
Q2 24
$41.2M
$11.9M
Q1 24
$35.4M
$6.6M
Total Debt
BKSY
BKSY
RMTI
RMTI
Q4 25
$201.1M
Q3 25
$195.1M
Q2 25
$122.5M
Q1 25
$115.3M
Q4 24
$107.7M
Q3 24
$98.8M
Q2 24
$108.6M
Q1 24
$85.0M
Stockholders' Equity
BKSY
BKSY
RMTI
RMTI
Q4 25
$94.9M
$37.0M
Q3 25
$91.1M
$37.0M
Q2 25
$86.6M
$30.4M
Q1 25
$88.8M
$31.5M
Q4 24
$94.0M
$32.6M
Q3 24
$110.3M
$29.1M
Q2 24
$76.5M
$23.5M
Q1 24
$81.7M
$20.6M
Total Assets
BKSY
BKSY
RMTI
RMTI
Q4 25
$386.2M
$57.1M
Q3 25
$380.9M
$57.5M
Q2 25
$310.8M
$52.6M
Q1 25
$284.9M
$54.0M
Q4 24
$254.1M
$59.2M
Q3 24
$245.5M
$57.1M
Q2 24
$224.3M
$53.0M
Q1 24
$210.1M
$50.7M
Debt / Equity
BKSY
BKSY
RMTI
RMTI
Q4 25
2.12×
Q3 25
2.14×
Q2 25
1.41×
Q1 25
1.30×
Q4 24
1.15×
Q3 24
0.90×
Q2 24
1.42×
Q1 24
1.04×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BKSY
BKSY
RMTI
RMTI
Operating Cash FlowLast quarter
$-9.3M
$2.3M
Free Cash FlowOCF − Capex
$2.2M
FCF MarginFCF / Revenue
12.0%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-1.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BKSY
BKSY
RMTI
RMTI
Q4 25
$-9.3M
$2.3M
Q3 25
$-39.0M
$-1.3M
Q2 25
$-7.3M
$1.8M
Q1 25
$27.2M
$-3.5M
Q4 24
$-1.8M
$865.0K
Q3 24
$1.0M
$4.3M
Q2 24
$-1.8M
$1.4M
Q1 24
$-3.8M
$-2.4M
Free Cash Flow
BKSY
BKSY
RMTI
RMTI
Q4 25
$2.2M
Q3 25
$-1.5M
Q2 25
$1.7M
Q1 25
$-3.5M
Q4 24
$470.0K
Q3 24
$4.1M
Q2 24
$1.2M
Q1 24
$-2.5M
FCF Margin
BKSY
BKSY
RMTI
RMTI
Q4 25
12.0%
Q3 25
-9.6%
Q2 25
10.5%
Q1 25
-18.8%
Q4 24
1.9%
Q3 24
14.4%
Q2 24
4.5%
Q1 24
-11.1%
Capex Intensity
BKSY
BKSY
RMTI
RMTI
Q4 25
0.5%
Q3 25
1.4%
Q2 25
1.0%
Q1 25
0.3%
Q4 24
1.6%
Q3 24
0.7%
Q2 24
1.1%
Q1 24
0.6%
Cash Conversion
BKSY
BKSY
RMTI
RMTI
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
2.57×
Q2 24
4.20×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BKSY
BKSY

Segment breakdown not available.

RMTI
RMTI

US$15.9M87%
Non Us$2.4M13%

Related Comparisons